News

What Results Does Bimekizumab Achieve in Patients with PsA After 3 Years of Treatment?

10. 8. 2023 Source: Psoriasis

Fresh findings from the BE ACTIVE study were published this year in the journal Rheumatology, which evaluated the effects of long-term treatment of individuals with psoriatic arthritis (PsA) with bimekizumab in terms of patient-reported outcomes (PROs).

Can Empagliflozin Also Act Against Gout?

Gliflozins, or sodium-glucose cotransporter 2 inhibitors (SGLT2i), are not only effective antidiabetic agents but also exhibit cardio -⁠ and renoprotective effects. It now appears that in type 2…

21. 7. 2023 Source: Diabetes

How does the level of uric acid affect the incidence of cardiorenal events in patients with T2DM and CVD?

One of the post hoc analyses of the well-known EMPA-REG OUTCOME study provided data on the relationship between uric acid levels and the incidence of cardiorenal events in type 2 diabetics with…

21. 7. 2023 Source: Diabetes

Treatment of Schizophrenia in a Patient at Risk of Developing Metabolic Syndrome –⁠ Interactive Case Study

A 34-year-old man has been under psychiatric care for 3 years due to a psychotic disorder. Three years ago, he had his first short hospitalization due to marked paranoid symptoms: feelings of being watched,...

17. 7. 2023 Source: Modern Treatment of Schizophrenia

Currently on the Issue of Interchangeability of Preparations with Levothyroxine in Practice

Levothyroxine (LT4) in oral form is the standard therapy for patients with hypothyroidism. Given the legislative possibility of generic substitution and the number of original and generic preparations...

17. 7. 2023 Source: Thyroid Disorders

INFOGRAPHIC: Determining the Target Intraocular Pressure in Glaucoma Therapy

The goal of glaucoma treatment is to preserve the visual field and the quality of life of patients. Currently, the only approach to preserving the visual field of patients is to reduce intraocular…

14. 7. 2023 Source: Treatment of Glaucoma

Effectiveness of Bisoprolol in Patients with Cardiac Arrhythmias –⁠ A Systematic Review of Studies

Last year, a Franco-Romanian team published a study that conducted a systematic review of existing evidence on bisoprolol in the context of arrhythmia treatment. The authors noted that bisoprolol,…

12. 7. 2023 Source: Cardiovascular Continuum

Which biomarkers can be used for risk stratification in ATTR cardiac amyloidosis?

Effective treatment for patients with transthyretin cardiac amyloidosis requires timely diagnosis and precise risk stratification to identify patients at higher risk of cardiovascular events, heart…

11. 7. 2023 Source: Amyloidosis

Results of a 10-year follow-up on the safety and efficacy of etanercept treatment in patients with juvenile idiopathic arthritis

Juvenile idiopathic arthritis (JIA) is defined as persistent arthritis of unknown etiology lasting > 6 weeks with the first onset before the age of 16. In the treatment of JIA, non-steroidal…

10. 7. 2023 Source: Arthritis

Tofacitinib Through the Eyes of Patients: Rapid Response After Treatment Initiation

How does tofacitinib fare in the treatment of ulcerative colitis in real clinical practice from the patients' perspective? This was addressed in a recent study published in the journal Inflammatory…

5. 7. 2023 Source: Intestinal Inflammations

Mental Health as an Overlooked Topic in Patients with Psoriasis

Psoriasis is an inflammatory, non-infectious disease primarily affecting the skin, and sometimes the nails, although in some patients, it manifests as psoriatic arthritis. To minimize the negative…

4. 7. 2023 Source: Psoriasis

Current Expert Consensus on Prophylaxis of Individuals with Mild and Moderate Hemophilia A: These Patients Also Deserve Better Care

What is the importance of prophylaxis in 'non-severe' hemophilia A? Italian doctors have attempted to answer this question in their recent expert consensus.

4. 7. 2023 Source: Hemophilia

Non-factor vs. Factor Prophylaxis of Hemophilia A: A Comparison of Cost and Treatment Effectiveness Based on Real-World Data from the USA

In the prophylactic treatment of patients with hemophilia A, particularly its severe form, concentrates of clotting factor VIII (FVIII) with extended half-life (EHL) are increasingly administered, or…

30. 6. 2023 Source: Hemophilia

When to Suspect Dravet Syndrome?

In 2022, an international consensus panel of experts on the diagnosis and treatment of Dravet syndrome was published. This was created due to the recently approved specific treatments for this…

29. 6. 2023 Source: Rare Diseases in Neurology

Medication in Patients with Myasthenia Gravis –⁠ What to Watch Out For?

According to current recommendations, the treatment of myasthenia gravis (MG) should be individualized, considering the severity of the disease, the type of autoantibodies, thymus pathology, and,…

29. 6. 2023 Source: Rare Diseases in Neurology

1 … 25 26 27 28 29 … 115

Back Filter by speciality

Remove filters

Popular this week